ERSAL, T. Et Al. 2023. Subcutaneos and ıntravenous cladribine treatment of Hairy Cell Leukemia patients: Do We still need ıntravenous cladribine?. UNIVERSOS JURÍDICOS , vol.5, no.2 , 109-116.

ERSAL, T., ÖZKALEMKAŞ, F., ÖZKOCAMAN, V., PINAR, İ. E., YALÇIN, C., ORHAN, B., ... CANDAR, Ö.(2023). Subcutaneos and ıntravenous cladribine treatment of Hairy Cell Leukemia patients: Do We still need ıntravenous cladribine?. UNIVERSOS JURÍDICOS , vol.5, no.2, 109-116.

ERSAL, TUBA Et Al. "Subcutaneos and ıntravenous cladribine treatment of Hairy Cell Leukemia patients: Do We still need ıntravenous cladribine?," UNIVERSOS JURÍDICOS , vol.5, no.2, 109-116, 2023

ERSAL, TUBA Et Al. "Subcutaneos and ıntravenous cladribine treatment of Hairy Cell Leukemia patients: Do We still need ıntravenous cladribine?." UNIVERSOS JURÍDICOS , vol.5, no.2, pp.109-116, 2023

ERSAL, T. Et Al. (2023) . "Subcutaneos and ıntravenous cladribine treatment of Hairy Cell Leukemia patients: Do We still need ıntravenous cladribine?." UNIVERSOS JURÍDICOS , vol.5, no.2, pp.109-116.

@article{article, author={TUBA ERSAL Et Al. }, title={Subcutaneos and ıntravenous cladribine treatment of Hairy Cell Leukemia patients: Do We still need ıntravenous cladribine?}, journal={UNIVERSOS JURÍDICOS}, year=2023, pages={109-116} }